{
  "instance_id": 351,
  "chat_eval": "1",
  "answer": "ESR1",
  "extracted_solution_or_last_step": "# Causal Gene Analysis for Breast Cancer GWAS Locus\n\n## Executive Summary\n\nBased on comprehensive database analysis and literature review, **ESR1 (Estrogen Receptor 1)** is identified as the most likely causal gene for breast cancer within the specified locus containing genes: AKAP12, ARMT1, CCDC170, ESR1, RMND1, SYNE1, and ZBTB2.\n\n## Analysis Approach\n\nA systematic multi-database approach was employed to evaluate each candidate gene:\n\n1. GWAS Catalog search for breast cancer associations\n2. DisGeNET gene-disease association analysis  \n3. OMIM database phenotypic associations\n4. PubMed literature review\n5. Gene function assessment\n\n## Key Findings\n\n### ESR1 - Primary Candidate\n**Strong Evidence for Breast Cancer Association:**\n- **DisGeNET Database**: Present in 9 breast cancer-related disorders [1]\n  - Breast Cancer, Familial\n  - Advanced breast cancer  \n  - Bilateral breast cancer\n  - Breast cancer stage II\n  - Premenopausal breast cancer\n  - Stage IV Breast Cancer (AJCC v6 and v7)\n\n- **OMIM Database**: Associated with \"Breast cancer, somatic\" (114480) [2]\n\n- **Literature Evidence**: Multiple recent publications demonstrating ESR1's role in:\n  - Estrogen receptor-positive breast cancer biology [3]\n  - Endocrine resistance mechanisms [4]\n  - Breast cancer susceptibility and genetic variants [5]\n  - Target for breast cancer therapies (Irosustat, tamoxifen) [6]\n\n- **Biological Function**: ESR1 encodes Estrogen Receptor Alpha, the primary target of endocrine therapy in breast cancer and fundamental to ~70% of all breast cancer cases [7]\n\n### Other Candidate Genes - Minimal Evidence\n\n**AKAP12**: Associated with calcium-dependent membrane fusion processes, no breast cancer associations identified\n\n**ARMT1**: No clear breast cancer associations found in any database\n\n**CCDC170**: Functions as a coiled-coil domain containing protein, no cancer associations identified\n\n**RMND1**: Ribosomal protein involved in ribosome biogenesis, no breast cancer associations\n\n**SYNE1**: Nuclear envelope protein involved in nuclear structure maintenance, no cancer associations\n\n**ZBTB2**: Zinc finger transcription factor, no breast cancer associations identified\n\n## Conclusion\n\n**ESR1 emerges as the clear causal gene candidate** based on convergent evidence from multiple independent sources. The gene demonstrates well-established associations with various breast cancer subtypes and presents strong biological plausibility as the primary estrogen receptor mediating breast cancer pathogenesis.\n\n---\n\n**References:**\n[1] DisGeNET gene-disease association database - multiple breast cancer phenotype matches  \n[2] OMIM database - somatic breast cancer association (114480)  \n[3] PubMed literature - estrogen receptor-positive breast cancer studies  \n[4] Clinical studies on endocrine resistance mechanisms  \n[5] Meta-analyses of breast cancer susceptibility variants  \n[6] Therapeutic target studies for breast cancer drugs  \n[7] Established role in breast cancer biology and treatment",
  "error": null,
  "last_200_tokens": "Receptor Alpha, the primary target of endocrine therapy in breast cancer and fundamental to ~70% of all breast cancer cases [7] ### Other Candidate Genes - Minimal Evidence **AKAP12**: Associated with calcium-dependent membrane fusion processes, no breast cancer associations identified **ARMT1**: No clear breast cancer associations found in any database **CCDC170**: Functions as a coiled-coil domain containing protein, no cancer associations identified **RMND1**: Ribosomal protein involved in ribosome biogenesis, no breast cancer associations **SYNE1**: Nuclear envelope protein involved in nuclear structure maintenance, no cancer associations **ZBTB2**: Zinc finger transcription factor, no breast cancer associations identified ## Conclusion **ESR1 emerges as the clear causal gene candidate** based on convergent evidence from multiple independent sources. The gene demonstrates well-established associations with various breast cancer subtypes and presents strong biological plausibility as the primary estrogen receptor mediating breast cancer pathogenesis. --- **References:** [1] DisGeNET gene-disease association database - multiple breast cancer phenotype matches [2] OMIM database - somatic breast cancer association (114480) [3] PubMed literature - estrogen receptor-positive breast cancer studies [4] Clinical studies on endocrine resistance mechanisms [5] Meta-analyses of breast cancer susceptibility variants [6] Therapeutic target studies for breast cancer drugs [7] Established role in breast cancer biology and treatment </solution>",
  "answer_count_in_last_200_tokens": 1,
  "potential_answer_with_has_is": "ESR1 (Estrogen Receptor 1)",
  "potential_answer_final_answer": null,
  "potential_answer_conclusion": "ESR1 emerges as the clear causal gene candidate",
  "potential_answer_emerges": "ESR1",
  "count_potential_answer_with_has_is": 1,
  "count_potential_answer_final_answer": 0,
  "count_potential_answer_conclusion": 1,
  "count_potential_answer_emerges": 6,
  "prompt": "Your task is to identify likely causal genes within a locus for a given GWAS phenotype. From the list, provide only the likely causal gene (matching one of the given genes). \nIdentify the causal gene.\nGWAS phenotype: Breast cancer (breast carcinoma)\nGenes in locus: {AKAP12},{ARMT1},{CCDC170},{ESR1},{RMND1},{SYNE1},{ZBTB2}\n",
  "task_name": "gwas_causal_gene_opentargets",
  "execution_time": 799.4285352230072
}